Purpose: To evaluate the occurrence, predisposing factors and outcome of persistent epithelial defects and ulcers complicating repeated corneal transplants.

Methods: The charts of all the patients that underwent repeated corneal transplantation between 1985 and 1998 were retrospectively reviewed for the presence of persistent epithelial defects and ulcers. The repeated corneal transplantation group included 122 regrafts performed in 80 patients. The follow-up period was at least 6 months after the last transplantation (average 31.5 months).

Results: Persistent epithelial defects and/or corneal ulcers affected 31 of the 122 regrafts (25.4%) in 23 patients (29%). Of the repeated grafts, 18 had persistent epithelial defects, five had ulcers and eight had persistent epithelial defects complicated by ulcers. Nine of the 31 regrafts (29%) that developed persistent epithelial defects or ulcers had positive bacterial cultures. The survival proportion was similar for regrafts with persistent epithelial defects and with ulcers (p = 0.859), but lower in the regrafted group with persistent epithelial defects and ulcers compared with the entire repeated corneal transplantation group (p < 0.001). In ten patients (43%), one or several eyelid abnormalities and ocular surface disorders were identified. They were more common in repeated keratoplasties with epithelial defects or ulcers than in repeated keratoplasties without them (p < 0.0001). Persistent epithelial defects developed more commonly after cyclocryotherapy for refractory glaucoma (p = 0.001).

Conclusions: Ulcers and persistent epithelial defects are common in repeated corneal transplantation and are associated with poor graft survival. Predisposing factors should be disclosed before regrafting and promptly treated.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00417-008-0797-4DOI Listing

Publication Analysis

Top Keywords

epithelial defects
48
persistent epithelial
44
defects ulcers
32
repeated corneal
24
corneal transplantation
20
defects
12
ulcers repeated
12
predisposing factors
12
persistent
11
ulcers
11

Similar Publications

SLC26A3 (DRA, the Congenital Chloride Diarrhea Gene): A Novel Therapeutic Target for Diarrheal Diseases.

Cell Mol Gastroenterol Hepatol

December 2024

- Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois, Chicago, IL, USA; - Jesse Brown VA Medical Center, Chicago, IL, USA. Electronic address:

Diarrhea associated with enteric infections, gut inflammation, and genetic defects poses a major health burden and results in significant morbidity and mortality. Impaired fluid and electrolyte absorption and/or secretion in the intestine are the hallmark of diarrhea. Electroneutral NaCl absorption in the mammalian GI tract involves the coupling of Na/H and Cl/HCO exchangers.

View Article and Find Full Text PDF

Inhibiting CFTR through inh-172 in primary neutrophils reveals CFTR-specific functional defects.

Sci Rep

December 2024

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

The lungs of people with cystic fibrosis (PwCF) are characterized by recurrent bacterial infections and inflammation. Infections in cystic fibrosis (CF) are left unresolved despite excessive neutrophil infiltration. The role of CFTR in neutrophils is not fully understood.

View Article and Find Full Text PDF

Mirvetuximab Soravtansine in solid tumors: A systematic review and meta-analysis.

PLoS One

December 2024

Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Background: Mirvetuximab Soravtansine (MIRV) is a promising antibody‒drug conjugate (ADC) that targets folate receptor alpha (FRα), which is overexpressed in several types of solid tumors. In November 2022, MIRV was approved in the USA for the treatment of adult patients with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer who received 1-3 prior systemic treatment regimens. Therefore, high-quality evidence for its efficacy and safety in different cancers is urgently needed.

View Article and Find Full Text PDF

Leber congenital amaurosis: A clinical and genetic study from a tertiary eye care center.

Indian J Ophthalmol

December 2024

Srimati Kanuri Santhamma Center for Vitreoretinal Diseases, Anant Bajaj Retina Institute, Kallam Anji Reddy Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Purpose: To assess the clinical phenotypes and genetic mutations in patients with Leber congenital amaurosis (LCA) from a tertiary eye care center in India.

Design: Retrospective observational study.

Methods: The study includes patients with a clinical diagnosis of LCA who underwent genetic testing from January 2016 to December 2021.

View Article and Find Full Text PDF

Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma.

Kidney Int

December 2024

Clinic of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site, Freiburg; Signalling Research Centres BIOSS and CIBSS, Faculty of Biology University of Freiburg, Freiburg, Germany. Electronic address:

RASSF1A is frequently biallelically inactivated in clear cell renal cell carcinoma (ccRCC) due to loss of chromosome 3p and promoter hypermethylation. Here we investigated the cellular and molecular consequences of single and combined deletion of the Rassf1a and Vhl tumor suppressor genes to model the common ccRCC genotype of combined loss of function of RASSF1A and VHL. In mouse embryonic fibroblasts and in primary kidney epithelial cells, double deletion of Rassf1a and Vhl caused chromosomal segregation defects and increased formation of micronuclei, demonstrating that pVHL and RASSF1A function to maintain genomic integrity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!